Maryland State Retirement & Pension System grew its position in Teleflex Incorporated (NYSE:TFX – Free Report) by 40.5% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 12,095 shares of the medical technology company’s stock after purchasing an additional 3,486 shares during the period. Maryland State Retirement & Pension System’s holdings in Teleflex were worth $1,512,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in TFX. BlackRock Inc. bought a new stake in shares of Teleflex in the 2nd quarter worth about $688,537,000. Jupiter Topco LLC acquired a new stake in shares of Teleflex during the 2nd quarter worth about $550,456,000. Irenic Capital Management LP bought a new position in Teleflex during the 1st quarter valued at about $104,061,000. Pzena Investment Management LLC bought a new position in Teleflex during the 2nd quarter valued at about $76,462,000. Finally, Bank of America Corp DE bought a new position in Teleflex during the 2nd quarter valued at about $61,156,000. Institutional investors and hedge funds own 95.62% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have commented on TFX. Mizuho set a $160.00 price target on shares of Teleflex in a research report on Friday, November 6th. Piper Sandler reaffirmed an “overweight” rating and set a $169.00 price objective (up from $160.00) on shares of Teleflex in a report on Friday, August 7th. Truist Financial raised their price objective on shares of Teleflex from $142.00 to $167.00 and gave the stock a “hold” rating in a report on Monday, November 9th. Wall Street Zen upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research note on Saturday, November 7th. Finally, Royal Bank Of Canada boosted their target price on Teleflex from $155.00 to $175.00 and gave the stock an “outperform” rating in a report on Friday, November 6th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $163.30.
Teleflex Price Performance
Shares of TFX stock opened at $155.00 on Monday. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $156.75. The stock has a market capitalization of $6.15 billion, a PE ratio of 18.83, a PEG ratio of 1.04 and a beta of 0.85. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.59 and a current ratio of 2.01. The stock’s fifty day moving average is $133.59 and its 200-day moving average is $127.37.
Teleflex (NYSE:TFX – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The medical technology company reported $2.63 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.73. The business had revenue of $567.80 million during the quarter, compared to analysts’ expectations of $565.52 million. Teleflex had a return on equity of 10.57% and a net margin of 13.51%. The firm’s revenue for the quarter was up .1% compared to the same quarter last year. During the same period in the previous year, the business posted $3.67 earnings per share. Equities research analysts expect that Teleflex Incorporated will post 7.67 EPS for the current fiscal year.
Teleflex Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 31st. Shareholders of record on Monday, November 16th will be given a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Monday, November 16th. Teleflex’s dividend payout ratio (DPR) is presently 16.52%.
About Teleflex
Teleflex is a global medical technology company that develops, manufactures and markets single-use medical devices used by healthcare professionals in hospitals and other care settings. Its products support a range of procedures, including vascular access, anesthesia, critical care, surgery, urology and emergency medicine. The company’s offerings include vascular and interventional access devices, catheters, airway management products, surgical instruments and other devices used in diagnostic and therapeutic procedures.
See Also
- Five stocks we like better than Teleflex
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.
